The biology of human natural killer-cell subsets (Q34430869)

2 August 2017

1 reference

title

The biology of human natural killer-cell subsets (English)

1 reference

natural killer cell differentiation involved in immune response

2 August 2017

main subject

1 reference

Gene Ontology release 2020-05-02

Cooper MA

1 reference

2 August 2017

Fehniger TA

series ordinal

1 reference

2 August 2017

Caligiuri MA

series ordinal

1 reference

2 August 2017

publication date

1 November 2001

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

633-640

1 reference

Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Expression of a functional c-kit receptor on a subset of natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Interleukin-1beta costimulates interferon-gamma production by human natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Differential phenotypic properties of human peripheral blood CD56dim+ and CD56bright+ natural killer cell subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Turning on natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

1 reference

7 January 2021

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Signal transduction during natural killer cell activation: inside the mind of a killer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Expression and regulation of chemokine receptors in human natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Chemokines and the arrest of lymphocytes rolling under flow conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

1 reference

7 January 2021

Functional expression of CD43 on human natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Expression of GPI-anchored complement regulatory proteins CD55 and CD59 differentiates two subpopulations of human CD56+ CD3- lymphocytes (NK cells).

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

On guard--activating NK cell receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Analysis of perforin expression in human peripheral blood lymphocytes, CD56+ natural killer cell subsets and its induction by interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Interleukin 15: biology and relevance to human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

The role of natural killer cells in innate resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Functions of human decidual NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

NK phenotypic markers and IL2 response in NK cells from elderly people.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Monoclonal antibody therapies-a 'constant' threat to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

Ontogeny and expansion of human natural killer cells: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902060-9

7 January 2021

10.1016/S1471-4906(01)02060-9

Identifiers

DOI

1 reference

2 August 2017

1 reference